United States Safety Lancets Market Report & Forecast 2021-2027
Table of Contents1 Introduction to Research & Analysis Reports
1.1 Safety Lancets Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Safety Lancets Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Safety Lancets Overall Market Size
2.1 United States Safety Lancets Market Size: 2021 VS 2027
2.2 United States Safety Lancets Revenue, Prospects & Forecasts: 2016-2027
2.3 United States Safety Lancets Sales: 2016-2027
3 Company Landscape
3.1 Top Safety Lancets Players in United States Market
3.2 Top United States Safety Lancets Companies Ranked by Revenue
3.3 United States Safety Lancets Revenue by Companies
3.4 United States Safety Lancets Sales by Companies
3.5 United States Safety Lancets Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Safety Lancets Companies in United States Market, by Revenue in 2020
3.7 Manufacturers Safety Lancets Product Type
3.8 Tier 1, Tier 2 and Tier 3 Safety Lancets Players in United States Market
3.8.1 List of Tier 1 Safety Lancets Companies in United States
3.8.2 List of Tier 2 and Tier 3 Safety Lancets Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Safety Lancets Market Size Markets, 2021 & 2027
4.1.2 Needle
4.1.3 Blade
4.2 By Type - United States Safety Lancets Revenue & Forecasts
4.2.1 By Type - United States Safety Lancets Revenue, 2016-2021
4.2.2 By Type - United States Safety Lancets Revenue, 2022-2027
4.2.3 By Type - United States Safety Lancets Revenue Market Share, 2016-2027
4.3 By Type - United States Safety Lancets Sales & Forecasts
4.3.1 By Type - United States Safety Lancets Sales, 2016-2021
4.3.2 By Type - United States Safety Lancets Sales, 2022-2027
4.3.3 By Type - United States Safety Lancets Sales Market Share, 2016-2027
4.4 By Type - United States Safety Lancets Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Safety Lancets Market Size, 2021 & 2027
5.1.2 Hospital and Clinics
5.1.3 Diagnostic Centers
5.1.4 Home Diagnostics
5.1.5 Others
5.2 By Application - United States Safety Lancets Revenue & Forecasts
5.2.1 By Application - United States Safety Lancets Revenue, 2016-2021
5.2.2 By Application - United States Safety Lancets Revenue, 2022-2027
5.2.3 By Application - United States Safety Lancets Revenue Market Share, 2016-2027
5.3 By Application - United States Safety Lancets Sales & Forecasts
5.3.1 By Application - United States Safety Lancets Sales, 2016-2021
5.3.2 By Application - United States Safety Lancets Sales, 2022-2027
5.3.3 By Application - United States Safety Lancets Sales Market Share, 2016-2027
5.4 By Application - United States Safety Lancets Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 Roche
6.1.1 Roche Corporation Information
6.1.2 Roche Overview
6.1.3 Roche Safety Lancets Sales and Revenue in United States Market (2016-2021)
6.1.4 Roche Safety Lancets Product Description
6.1.5 Roche Recent Developments
6.2 BD
6.2.1 BD Corporation Information
6.2.2 BD Overview
6.2.3 BD Safety Lancets Sales and Revenue in United States Market (2016-2021)
6.2.4 BD Safety Lancets Product Description
6.2.5 BD Recent Developments
6.3 Bayer
6.3.1 Bayer Corporation Information
6.3.2 Bayer Overview
6.3.3 Bayer Safety Lancets Sales and Revenue in United States Market (2016-2021)
6.3.4 Bayer Safety Lancets Product Description
6.3.5 Bayer Recent Developments
6.4 Lifescan
6.4.1 Lifescan Corporation Information
6.4.2 Lifescan Overview
6.4.3 Lifescan Safety Lancets Sales and Revenue in United States Market (2016-2021)
6.4.4 Lifescan Safety Lancets Product Description
6.4.5 Lifescan Recent Developments
6.5 B. Braun
6.5.1 B. Braun Corporation Information
6.5.2 B. Braun Overview
6.5.3 B. Braun Safety Lancets Sales and Revenue in United States Market (2016-2021)
6.5.4 B. Braun Safety Lancets Product Description
6.5.5 B. Braun Recent Developments
6.6 Terumo
6.6.1 Terumo Corporation Information
6.6.2 Terumo Overview
6.6.3 Terumo Safety Lancets Sales and Revenue in United States Market (2016-2021)
6.6.4 Terumo Safety Lancets Product Description
6.6.5 Terumo Recent Developments
6.7 Nipro
6.7.1 Nipro Corporation Information
6.7.2 Nipro Overview
6.7.3 Nipro Safety Lancets Sales and Revenue in United States Market (2016-2021)
6.7.4 Nipro Safety Lancets Product Description
6.7.5 Nipro Recent Developments
6.8 Sarstedt
6.8.1 Sarstedt Corporation Information
6.8.2 Sarstedt Overview
6.8.3 Sarstedt Safety Lancets Sales and Revenue in United States Market (2016-2021)
6.8.4 Sarstedt Safety Lancets Product Description
6.8.5 Sarstedt Recent Developments
6.9 ARKRAY
6.9.1 ARKRAY Corporation Information
6.9.2 ARKRAY Overview
6.9.3 ARKRAY Safety Lancets Sales and Revenue in United States Market (2016-2021)
6.9.4 ARKRAY Safety Lancets Product Description
6.9.5 ARKRAY Recent Developments
6.10 Smiths Medical
6.10.1 Smiths Medical Corporation Information
6.10.2 Smiths Medical Overview
6.10.3 Smiths Medical Safety Lancets Sales and Revenue in United States Market (2016-2021)
6.10.4 Smiths Medical Safety Lancets Product Description
6.10.5 Smiths Medical Recent Developments
6.11 Owen Mumford
6.11.1 Owen Mumford Corporation Information
6.11.2 Owen Mumford Overview
6.11.3 Owen Mumford Safety Lancets Sales and Revenue in United States Market (2016-2021)
6.11.4 Owen Mumford Safety Lancets Product Description
6.11.5 Owen Mumford Recent Developments
6.12 HemoCue
6.12.1 HemoCue Corporation Information
6.12.2 HemoCue Overview
6.12.3 HemoCue Safety Lancets Sales and Revenue in United States Market (2016-2021)
6.12.4 HemoCue Safety Lancets Product Description
6.12.5 HemoCue Recent Developments
6.13 Greiner Bio One
6.13.1 Greiner Bio One Corporation Information
6.13.2 Greiner Bio One Overview
6.13.3 Greiner Bio One Safety Lancets Sales and Revenue in United States Market (2016-2021)
6.13.4 Greiner Bio One Safety Lancets Product Description
6.13.5 Greiner Bio One Recent Developments
7 United States Safety Lancets Production Capacity, Analysis
7.1 United States Safety Lancets Production Capacity, 2016-2027
7.2 Safety Lancets Production Capacity of Key Manufacturers in United States Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Safety Lancets Supply Chain Analysis
9.1 Safety Lancets Industry Value Chain
9.2 Safety Lancets Upstream Market
9.3 Safety Lancets Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Safety Lancets Distributors and Sales Agents in United States Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of TablesTable 1. Key Players of Safety Lancets in United States Market
Table 2. Top Safety Lancets Players in United States Market, Ranking by Revenue (2019)
Table 3. United States Safety Lancets Revenue by Companies, (US$, Mn), 2016-2021
Table 4. United States Safety Lancets Revenue Share by Companies, 2016-2021
Table 5. United States Safety Lancets Sales by Companies, (M Units), 2016-2021
Table 6. United States Safety Lancets Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Safety Lancets Price (2016-2021) & (USD/Unit)
Table 8. Manufacturers Safety Lancets Product Type
Table 9. List of Tier 1 Safety Lancets Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Safety Lancets Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Needle
Table 12. Major Manufacturers of Blade
Table 13. By Type - United States Safety Lancets Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - United States Safety Lancets Revenue (US$, Mn), 2016-2021
Table 15. By Type - United States Safety Lancets Revenue (US$, Mn), 2022-2027
Table 16. By Type - United States Safety Lancets Sales (M Units), 2016-2021
Table 17. By Type - United States Safety Lancets Sales (M Units), 2022-2027
Table 18. By Application - United States Safety Lancets Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - United States Safety Lancets Revenue (US$, Mn), 2016-2021
Table 20. By Application - United States Safety Lancets Revenue (US$, Mn), 2022-2027
Table 21. By Application - United States Safety Lancets Sales (M Units), 2016-2021
Table 22. By Application - United States Safety Lancets Sales (M Units), 2022-2027
Table 23. Roche Corporation Information
Table 24. Roche Description and Major Businesses
Table 25. Roche Safety Lancets Sales (M Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 26. Roche Safety Lancets Product
Table 27. Roche Recent Developments
Table 28. BD Corporation Information
Table 29. BD Description and Major Businesses
Table 30. BD Safety Lancets Sales (M Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 31. BD Safety Lancets Product
Table 32. BD Recent Developments
Table 33. Bayer Corporation Information
Table 34. Bayer Description and Major Businesses
Table 35. Bayer Safety Lancets Sales (M Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 36. Bayer Safety Lancets Product
Table 37. Bayer Recent Developments
Table 38. Lifescan Corporation Information
Table 39. Lifescan Description and Major Businesses
Table 40. Lifescan Safety Lancets Sales (M Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 41. Lifescan Safety Lancets Product
Table 42. Lifescan Recent Developments
Table 43. B. Braun Corporation Information
Table 44. B. Braun Description and Major Businesses
Table 45. B. Braun Safety Lancets Sales (M Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 46. B. Braun Safety Lancets Product
Table 47. B. Braun Recent Developments
Table 48. Terumo Corporation Information
Table 49. Terumo Description and Major Businesses
Table 50. Terumo Safety Lancets Sales (M Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 51. Terumo Safety Lancets Product
Table 52. Terumo Recent Developments
Table 53. Nipro Corporation Information
Table 54. Nipro Description and Major Businesses
Table 55. Nipro Safety Lancets Sales (M Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 56. Nipro Safety Lancets Product
Table 57. Nipro Recent Developments
Table 58. Sarstedt Corporation Information
Table 59. Sarstedt Description and Major Businesses
Table 60. Sarstedt Safety Lancets Sales (M Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 61. Sarstedt Safety Lancets Product
Table 62. Sarstedt Recent Developments
Table 63. ARKRAY Corporation Information
Table 64. ARKRAY Description and Major Businesses
Table 65. ARKRAY Safety Lancets Sales (M Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 66. ARKRAY Safety Lancets Product
Table 67. ARKRAY Recent Developments
Table 68. Smiths Medical Corporation Information
Table 69. Smiths Medical Description and Major Businesses
Table 70. Smiths Medical Safety Lancets Sales (M Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 71. Smiths Medical Safety Lancets Product
Table 72. Smiths Medical Recent Developments
Table 73. Owen Mumford Corporation Information
Table 74. Owen Mumford Description and Major Businesses
Table 75. Owen Mumford Safety Lancets Sales (M Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 76. Owen Mumford Safety Lancets Product
Table 77. Owen Mumford Recent Developments
Table 78. HemoCue Corporation Information
Table 79. HemoCue Description and Major Businesses
Table 80. HemoCue Safety Lancets Sales (M Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 81. HemoCue Safety Lancets Product
Table 82. HemoCue Recent Developments
Table 83. Greiner Bio One Corporation Information
Table 84. Greiner Bio One Description and Major Businesses
Table 85. Greiner Bio One Safety Lancets Sales (M Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 86. Greiner Bio One Safety Lancets Product
Table 87. Greiner Bio One Recent Developments
Table 88. Safety Lancets Production Capacity (M Units) of Key Manufacturers in United States Market, 2019-2021 (M Units)
Table 89. United States Safety Lancets Capacity Market Share of Key Manufacturers, 2019-2021
Table 90. Safety Lancets Market Opportunities & Trends in United States Market
Table 91. Safety Lancets Market Drivers in United States Market
Table 92. Safety Lancets Market Restraints in United States Market
Table 93. Safety Lancets Raw Materials
Table 94. Safety Lancets Raw Materials Suppliers in United States Market
Table 95. Typical Safety Lancets Downstream
Table 96. Safety Lancets Downstream Clients in United States Market
Table 97. Safety Lancets Distributors and Sales Agents in United States Market
List of FiguresFigure 1. Safety Lancets Product Picture
Figure 2. Safety Lancets Segment by Type
Figure 3. Safety Lancets Segment by Application
Figure 4. United States Safety Lancets Market Overview: 2020
Figure 5. United States Safety Lancets Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. United States Safety Lancets Revenue, 2016-2027 (US$, Mn)
Figure 7. Safety Lancets Sales in United States Market: 2016-2027 (M Units)
Figure 8. The Top 3 and 5 Players Market Share by Safety Lancets Revenue in 2020
Figure 9. Needle Product Picture
Figure 10. Blade Product Picture
Figure 11. By Type - United States Safety Lancets Sales Market Share, 2016-2027
Figure 12. By Type - United States Safety Lancets Revenue Market Share, 2016-2027
Figure 13. By Type - United States Safety Lancets Price (USD/Unit), 2016-2027
Figure 14. Hospital and Clinics
Figure 15. Diagnostic Centers
Figure 16. Home Diagnostics
Figure 17. Others
Figure 18. By Application - United States Safety Lancets Sales Market Share, 2016-2027
Figure 19. By Application - United States Safety Lancets Revenue Market Share, 2016-2027
Figure 20. By Application - United States Safety Lancets Price (USD/Unit), 2016-2027
Figure 21. Roche Safety Lancets Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 22. BD Safety Lancets Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. Bayer Safety Lancets Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Lifescan Safety Lancets Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. B. Braun Safety Lancets Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. Terumo Safety Lancets Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. Nipro Safety Lancets Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. Sarstedt Safety Lancets Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 29. ARKRAY Safety Lancets Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 30. Smiths Medical Safety Lancets Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 31. Owen Mumford Safety Lancets Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 32. HemoCue Safety Lancets Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 33. Greiner Bio One Safety Lancets Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 34. United States Safety Lancets Production Capacity (M Units), 2016-2027
Figure 35. Safety Lancets Industry Value Chain
Figure 36. Marketing Channels